Geneos Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4K | Buy |
669
+50
| +8% | +$1.08K | ﹤0.01% | 2171 |
|
|
2025
Q1 | $26.5K | Buy |
619
+284
| +85% | +$12.2K | ﹤0.01% | 2209 |
|
|
2024
Q4 | $6.15K | Buy |
335
+57
| +21% | +$1.05K | ﹤0.01% | 2254 |
|
|
2024
Q3 | $4.28K | Buy |
+278
| New | +$4.28K | ﹤0.01% | 2117 |
|
|
2022
Q3 | – | Sell |
-450
| Closed | -$6K | – | 1995 |
|
|
2022
Q2 | $6K | Hold |
450
| – | – | ﹤0.01% | 2111 |
|
|
2022
Q1 | $10K | Hold |
450
| – | – | ﹤0.01% | 2078 |
|
|
2021
Q4 | $10K | Hold |
450
| – | – | ﹤0.01% | 2161 |
|
|
2021
Q3 | $7K | Hold |
450
| – | – | ﹤0.01% | 2326 |
|
|
2021
Q2 | $10K | Hold |
450
| – | – | ﹤0.01% | 2186 |
|
|
2021
Q1 | $9K | Hold |
450
| – | – | ﹤0.01% | 2402 |
|
|
2020
Q4 | $11K | Hold |
450
| – | – | ﹤0.01% | 2166 |
|
|
2020
Q3 | $18K | Hold |
450
| – | – | ﹤0.01% | 1689 |
|
|
2020
Q2 | $21K | Hold |
450
| – | – | ﹤0.01% | 1587 |
|
|
2020
Q1 | $17K | Hold |
450
| – | – | ﹤0.01% | 1566 |
|
|
2019
Q4 | $19K | Hold |
450
| – | – | ﹤0.01% | 1701 |
|
|
2019
Q3 | $16K | Sell |
450
-417
| -48% | -$14.8K | ﹤0.01% | 1698 |
|
|
2019
Q2 | $23K | Hold |
867
| – | – | ﹤0.01% | 1557 |
|
|
2019
Q1 | $23K | Hold |
867
| – | – | ﹤0.01% | 1496 |
|
|
2018
Q4 | $13K | Hold |
867
| – | – | ﹤0.01% | 1680 |
|
|
2018
Q3 | $17K | Sell |
867
-2,300
| -73% | -$45.1K | ﹤0.01% | 1641 |
|
|
2018
Q2 | $48K | Hold |
3,167
| – | – | ﹤0.01% | 1062 |
|
|
2018
Q1 | $71K | Buy |
3,167
+3,017
| +2,011% | +$67.6K | 0.01% | 864 |
|
|
2017
Q4 | $4K | Buy |
+150
| New | +$4K | ﹤0.01% | 1853 |
|
|
2017
Q2 | – | Sell |
-63
| Closed | -$2K | – | 2066 |
|
|
2017
Q1 | $2K | Hold |
63
| – | – | ﹤0.01% | 1851 |
|
|
2016
Q4 | $1K | Hold |
63
| – | – | ﹤0.01% | 1917 |
|
|
2016
Q3 | $2K | Buy |
+63
| New | +$2K | ﹤0.01% | 1739 |
|
|
2016
Q2 | – | Sell |
-1,000
| Closed | -$28K | – | 1800 |
|
|
2016
Q1 | $28K | Buy |
+1,000
| New | +$28K | ﹤0.01% | 983 |
|